Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

- PMLiVE

Johnson & Johnson’s Tremfya shows promise in ‘special site’ plaque psoriasis

The immune-mediated disease affects more than 125 million people worldwide

- PMLiVE

Delivering inclusive events

When talking about diversity and inclusion, we also need to consider those disabilities that are not visible

Generative AI platforms drive drug discovery dealmaking

AI-Driven Platforms Enhance Drug Discovery Collaborations

Generative AI platforms are revolutionizing drug discovery, driving significant biopharma dealmaking by enabling the design of innovative small-molecule and biologic drug candidates.

Springer Nature

- PMLiVE

Medscape Education presenting at the 17th Annual European CME Forum

With a commitment to advancing the field of continuing medical education, the Medscape team will be travelling to Madrid for the 17th Annual European CME Forum and bringing with them...

Medscape Education

- PMLiVE

Pfizer’s Elrexfio recommended by NICE to treat relapsed and refractory multiple myeloma

Approximately 5,000 people are diagnosed with the disease every year in England

- PMLiVE

Eli Lilly shares positive results for modified titration of Alzheimer’s drug donanemab

The neurodegenerative disorder accounts for up to 75% of the 982,000 dementia cases in the UK

- PMLiVE

Serving up customer experience excellence

Pharma struggles to differentiate the experiences it provides, missing opportunities to achieve desirable business results and help HCPs at their point of need

- PMLiVE

How Innovative Trials are making a difference to clinical trials in the US

Eloise Moffett, Innovative Trials’ Vice President of Commercial, reflects on how the company’s growing presence in the US is transforming client relationships and its ability to provide the best patient-centric...

Innovative Trials

- PMLiVE

Pharma-exclusive Webinar: Next-gen Virtual Tools for Education & Learning in the Life Sciences

Unlock the potential of next-gen virtual tools in our upcoming webinar. From AI simulations to interactive AR booths, learn how to effectively apply these technologies in life sciences education and...

Impetus Digital

- PMLiVE

Merck acquires oncology spinout Modifi Biosciences in deal worth $1.3bn

The agreement gives Merck access to a new class of small molecules for difficult-to-treat cancers

- PMLiVE

BeiGene’s Tevimbra recommended by CHMP for gastric and oesophageal cancer

Gastric cancer is the fifth leading cause of cancer-related deaths globally, while oesophageal cancer is the sixth

- PMLiVE

Medicines can be beyond reach – unless…

Solving the access to medicines problem needs an evolutionary leap

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links